Dr. de Botton is a physician, clinical investigator and head of drug development in acute leukemias in the Department of Hematology at Gustave Roussy Cancer Center in Villejuif, France. He also belongs to the research unit UMR 1170 for novel preclinical research. He is a member of the executive board of the Acute Leukemia French Association (ALFA) that focuses on the clinical and translational research in adult acute myeloid leukemia.


About

